PRNewswire, 11 August 2016
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Nymox Pharmaceutical Corporation (“Nymox” or the “Company”) (NASDAQ: NYMX) and certain of its officers and directors violated federal securities laws.
Nymox shares plummeted nearly 41% on August 10, 2016, after an article titled “Nymox: This Offshore ‘Biotech’ Promotion Will Go To Zero (Yes, Zero)” was published on the investment research site Seeking Alpha, reporting that Nymox has and continues to mislead shareholders about the Company’s prospects, while “dumping millions in stock without making timely SEC disclosures.” The revelation of Nymox’s fraudulent conduct has caused tens of millions in losses to Nymox investors.
